Results 1 to 10 of about 5,276 (179)
Superficial malignant peripheral nerve sheath tumor from recurrent neurofibroma in the abdominal wall of a patient without neurofibromatosis type 1 [PDF]
Yeungnam University Journal of Medicine, 2019 Malignant peripheral nerve sheath tumor (MPNST) is rare, accounting for 5–10% of all soft tissue sarcomas. MPNST is characteristically aggressive and has a poor prognosis. Fifty percent of patients with MPNST have neurofibromatosis type 1 (NF1).
Chang Yeon Jung +3 more
doaj +1 more source
HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST). [PDF]
PLoS ONE, 2015 HDAC isoform-specific inhibitors may improve the therapeutic window while limiting toxicities. Developing inhibitors against class I isoforms poses difficulties as they share high homology among their catalytic sites; however, HDAC8 is structurally ...
Gonzalo Lopez +9 more
doaj +1 more source
Digital Diagnostics, 2023 INTRODUCTION: Malignant peripheral nerve sheath tumor (MPNST) occurs in young and middle-aged people, more frequently in those with the genetic disease known as neurofibromatosis type 1 (NF1).
Anna A. Gofman +4 more
doaj +1 more source
Nature Communications, 2023 Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive sarcoma, and a lethal neurofibromatosis type 1-related malignancy, with little progress made on treatment strategies.
Suganth Suppiah +23 more
doaj +1 more source
Impaired Pten expression in human malignant peripheral nerve sheath tumours. [PDF]
PLoS ONE, 2012 Malignant peripheral nerve sheath tumours (MPNST) are aggressive sarcomas that develop in about 10% of patients with the genetic disease neurofibromatosis type 1 (NF1).
Maren Bradtmöller +12 more
doaj +1 more source
Huge Malignant Peripheral Nerve Sheath Tumors Originating In Neurofibromatosis Type 1
Journal of Rawalpindi Medical College, 2023 Malignant peripheral nerve sheath tumors (MPNST) are malignant soft tissue neoplasms which account for 2% of all soft tissue sarcomas. These tumors are associated with poor prognosis, propensity to metastasize and high recurrence rates.
Nabeela Riaz, Samreen Younas
doaj +1 more source
Frontiers in Neurology, 2023 Brachial plexopathy (BP) is easily misdiagnosed due to its complexity and varying clinical presentation. Malignant peripheral nerve sheath tumors (MPNST) can accumulate in the brachial plexus and share symptoms with BP, which may hinder the differential ...
Mengjie Chen, Xiuli Li, Xinhong Feng
doaj +1 more source
A worldwide bibliometric analysis of malignant peripheral nerve sheath tumors from 2000 to 2022
Frontiers in Oncology, 2023 BackgroundCurrently, malignant peripheral nerve sheath tumors (MPNST) are the subject of intense research interest. However, bibliometric studies have not been conducted in this field.
Xingfeng Huang +11 more
doaj +1 more source
Radiology Appearance of Malignant Peripheral Nerve Sheath Tumor: a Case Report
Indonesian Journal of Cancer, 2009 Malignant peripheral nerve sheath tumor (MPNST) is a rare soft tissue sarcoma. This tumor included up to 10% of 1-2 of 100,000 population/year soft tissue sarcoma.
Aziza G Icksan +3 more
doaj +1 more source
PLoS ONE, 2017 Malignant peripheral nerve sheath tumors (MPNST) are rare, highly aggressive sarcomas that can occur spontaneously or from pre-existing plexiform neurofibromas in neurofibromatosis type1 (NF1) patients.
Azadeh Amirnasr +5 more
doaj +1 more source